Section Arrow
Quote
HBIO.NASDAQ
- Harvard Bioscience
(Financial Status)
Quotes are at least 15-min delayed:2025/11/15 01:11 EST
Regular Hours
Last
 0.6596
+0.0774 (+13.29%)
Day High 
0.6698 
Prev. Close
0.5822 
1-M High
0.94 
Volume 
2.05M 
Bid
0.6502
Ask
0.6574
Day Low
0.5425 
Open
0.5569 
1-M Low
0.3755 
Market Cap 
25.95M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.58 
20-SMA 0.5 
50-SMA 0.47 
52-W High 2.4 
52-W Low 0.2813 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.29/0.36
Enterprise Value
32.34M
Balance Sheet
Book Value Per Share
0.32
Cash Flow
Cash Flow Yield
0.33
Income Statement
Total Revenue
94.14M
Operating Revenue Per Share
2.52
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
MLSSMilestone Scientific0.33-0.0497-13.09%-- 
AVTRAvantor11.38-0.32-2.74%11.55PE
BAXBaxter International18.47-0.23-1.23%140.32PE
HOLXHologic74.15-0.11-0.15%30.81PE
XRAYDENTSPLY SIRONA10.52-0.43-3.93%-- 
Quotes are at least 15-min delayed：2025/11/15 01:11 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.